NCT05812417View on ClinicalTrials.gov

A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

June 7, 2024

Study Completion Date

June 7, 2024

Conditions
Renal ImpairmentHealthy
Interventions
DRUG

DA-8010

DA-8010 5mg single dose administration

Trial Locations (1)

Unknown

CHA Bundang Medical Center, Gyeonggi-do

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT05812417 - A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010 | Biotech Hunter | Biotech Hunter